Fact CheckerSign in

NCT06344767Completed

Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor

Positive Estrogen Receptor (ER) Expression Assessed by 18F-fluoroestradiol Positron Emission Tomography/Computed Tomography (18F-FES PET/CT) in the Metastatic Breast Cancer (MBC) with ER- Negative Primary Tumor

Source: ClinicalTrials.gov · Last updated 8 Oct 2024

Brief summary (registry, in English)

To investigate the treatment pattern and efficacy of patients with negative primary ER lesion but positive ER expression in MBC using a novel convenient way of 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PET/CT).

Status (registry)
Completed
Study type
Observational
Enrollment
19 (actual)
First submitted
28 Mar 2024
Start date
1 Sept 2023
Primary completion date
5 May 2024
Lead sponsor
Fudan University
NCT number
NCT06344767

What you commit to

  • Study type: Observational
  • Participants enrolled: 19
  • From 1 Sept 2023 to the primary completion date, 5 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients with incomplete medical records and those diagnosed with secondary primary tumors

Who the study is looking for

  • Patients diagnosed with breast cancer (according to International Classification of Diseases 10th Revision) with confirmed metastasis, regardless of being de novo diagnosed or progressed from a nonmetastatic stage.
  • MBC patients who underwent 18F-FES PET/CT at the Fudan University Shanghai Cancer Center between 2012 and 2023
  • Patients diagnosed with primary ER-negative tumor and who were yet to receive any systemic therapy during the advanced stage

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
China,Shanghai
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.